COVID-19 Symposia

Starting feb. 7, 2022

COVID-19 Symposia

The UF CTSI brings together researchers from the University of Florida and Florida State University to share research outcomes and collaborate on opportunities to advance clinical and translational science.

A close-up image of a COVID-19 testing swab

Schedule & Registration

COVID 19 Clinical and Translational Science Updates: Lightning Sessions – 5-minute presentations (Zoom)

date/time subject Register Presentations
Monday, Feb. 7, 10 a.m. – Noon Clinical Care; Therapeutics & Vaccines Register to attend View presentations
Wednesday, Feb. 9, 10 a.m. – Noon Detection, Surveillance & Risk Factors Register to attend View presentations
Wednesday, Feb. 9, 2 – 4 p.m. Dissemination, Policy, Public Information, PPE & Health Care Delivery Register to attend View presentations
Thursday, Feb. 10, 3 – 5 p.m. Mental Health; Using Data Register to attend View presentations
Friday, Feb. 11, 1 – 3 p.m. Social Determinants of Health; Medical Engineering Register to attend View presentations

Present Your Research

If you are interested in presenting your own research during these sessions, please let us know by completing this form We will limit presentations per session to 12.


Presentations

COVID 19 Clinical and Translational Science Updates: Lightning Sessions – 5-minute presentations (Zoom). Additional presenters and presentations may be added – check back for updates!

Clinical Care, Therapeutics & Vaccines – Feb. 7, 10 a.m. – noon

presenter presentation title
Lyle Moldawer, MD Immunological Description of COVID19 Sepsis vs Bacterial Sepsis
Nicole Iovine, MD A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Matthew Schaller, PhD Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses
Elizabeth Shenkman, MD ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
Leah Reznikov, PhD Targeted disruption of ACE2-SARS-CoV-2 interactions using small molecules

Detection, Surveillance & Risk Factors – Feb. 9, 10 a.m. – noon

presenter presentation title
Josephine Esquivel-Upshaw, DMD A handheld electrical sensor for rapid, sensitive detection and quantification of SARS-CoV-2 from saliva
Kartik Cherabuddi, PhD COVID-19 vaccine and infection in young adults and university system
Christopher Vulpe, MD, PhD Identification of host determinants of SARS-CoV-2 infection
Jane Benoit, PhD Human coronavirus proteins alter chromatin dynamics

Dissemination, Policy, Public Information, PPE & Health Care Delivery – Feb. 9, 2-4 p.m.

presenter presentation title
Eric Cooks, PhD This research will explore provider perspectives for strengthening research partnerships to implement cancer screening interventions during the COVID-19 pandemic.
Steven Munger, PhD Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance
Elizabeth Shenkman, MD Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
Carma Bylund, PhD Doctor-Patient Cancer Communications through Telemedicine during COVID-19

Mental Health and Using Data – Feb. 10, 3-5 p.m.

presenter presentation title
Nicola Sambuco, PhD Exposure to COVID-19 trauma and risk factors for developing psychopathology
Elizabeth Shenkman, MD Primary Data Collection, Active Surveillance Study of Post-Vaccination Events of Interest Among Patients Vaccinated with Pfizer/BioNTech COVID-19 Vaccine or HERO-TOGETHER Registry
Tanja Magoc, PhD Rapid Creation of a De-Identified COVID-19 Dataset for Clinical Research

Social Determinants of Health, Medical Engineering – Feb. 11, 1-3 p.m.

presenter presentation title
Lauri Baker, PhD Lessons from COVID-19: Positioning Regional Food Supply Chains for Future Pandemics, Natural Disasters and Human-made Crises
Michelle Danyluk, PhD A collaborative approach to managing SARS-CoV-2 within the food industry; filling data gaps and impacting behaviors
Elizabeth Shenkman, MD Community-Engagement Research Alliance Against COVID-19 in Disproportionately Affected Communities (CEAL)
Melissa Radey, PhD Social Support and Well-being Among Low-income Mothers During the COVID-19 Pandemic
Zhonghui Fan,PhD Multiplexed Airborne Virus Collection and Detection at the Point-of-Care

Community Engagement and COVID-19

Postponed – Date TBD

During this session, leaders from across UF and FSU will share highlights of their work, research and programs.

Conducting COVID-19 Research

Monday, March 28, 9 a.m. – Noon

Research services and core facilities across campus created new workflows, new opportunities and continue to advance research capabilities at UF and FSU. Hear from those who help you conduct your research.

2020 Pilot Awardees

The CTSI and the Office of the Senior Vice President for Health Affairs created a $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized.